Matouš Hrdinka, Ph.D.

Dr. Matouš Hrdinka stands at the forefront of cancer biology and molecular immunology research, focusing on uncovering the intricate mechanisms of ubiquitin and kinase oncogenic signaling and advancing antibody and cell-based immunotherapies. With over a decade of experience in both academic and pharmaceutical sectors, Dr. Hrdinka has distinguished himself as an accomplished senior scientist and

Scroll to Top